Pharmaceuticals

Canada DNA Vaccine Market Size, Share, Trends, Analysis and Forecast 2019-2025

April 08, 2020 by OMRGlobal

Canada DNA Vaccine market is anticipated to grow at a CAGR 41.6% during the forecast period. There are various factors driving the growth of the DNA vaccination market in Canada. This includes increasing healthcare expenditure, investment by cancer research organizations and increasing prevalence of cancer. In May 2017, Canadian Gary kobinger has set to overcome the Zika virus by developing a DNA vaccine. Mice are used in the earlier test of the vaccine. Moreover, the experimental vaccine referred to as GLS-5700, protected all the mice from brain damage, zika infection and death. The vaccine also triggered a robust immune response in the monkeys. The vaccine is also expected to protect the child of pregnant women from Zika infection as well as protect it from microcephaly.

A full report of Canada DNA Vaccine Market is available at:  https://www.omrglobal.com/industry-reports/canada-dna-vaccines-market

Apart from this, Dr. Weiner, specialized in DNA vaccines along with Dr.Kobinger has led the development of Ebola drug ZMapp at the National Microbiology Laboratory in Winnipeg. It is under phase 1 human trials regarding DNA vaccines for MERS and Ebola. Likewise, the studies for HIV have also conducted by Gary Kobinger at Canada's National Microbiology Laboratory in Winnipeg. It shows a high focus on R&D for DNA vaccination in Canada, which may result in widening the possibilities of the Canada DNA vaccination market for the effective treatment of several diseases. 

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/canada-dna-vaccines-market

Furthermore, an increased prevalence of cancer is also expected to augment the Canada DNA vaccination market. According to the Canadian Cancer Statistics, it was estimated that around 1 in 2 Canadian will have cancer in a lifetime. On the other hand, 1 out of 4 will have mortality due to cancer. The key market player that is active in the market includes Arbutus Biopharma Corp., Dendreon Pharmaceuticals LLC, GE Healthcare, GlaxoSmithKline PLC., Green Cross Corp., Innovio Biomedical Corp., Immunomic Therapeutics, Merck & Co., Pfizer Inc., Protein Sciences Corp., and Sanofi Inc. among other.

Canada DNA Vaccine Market- Segmentation

by Type
  • Animal DNA Vaccine
  • Human DNA Vaccine
by Technology
  • Plasmid DNA Vaccine
  • Plasmid DNA Delivery
by Application
  • Oncology
  • Infectious Disease
  • Others
For more customized data, request for report customization @  https://www.omrglobal.com/report-customization/canada-dna-vaccines-market

Company Profiles
  • Arbutus Biopharma Corp.
  • Dendreon Pharmaceuticals LLC
  • GE Healthcare
  • Glaxosmithkline PLC.
  • Immunomic Therapeutics
  • Innovio Biomedical Corp.
  • Merck & Co.
  • Pfizer Inc.
  • Protein Sciences Corp.
  • Sanofi Inc.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research


Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

0 Comments

0 Comments

Post a Comment